CARM
CARISMA THERAPEUTICS INCstockOTC
eleven biotherapeutics is focused on translating breakthrough discoveries from science and medicine to engineer and develop innovative protein-based therapeutics to improve human health and treat disease. eleven biotherapeutics' scientists are engineering protein-based drugs using newly available structural information and the company's unique molecular understanding of clinical effects to create the next generation of protein-based medicines to treat important diseases with unmet needs, such as inflammatory conditions and coagulation disorders.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.00 | 2026-09-28 | -28.57% | -2.259 |
| 1M | 0.00 | 2026-09-04 | -28.57% | 4.430 |
| 3M | 0.01 | 2026-07-06 | -91.53% | -5.564 |
| 6M | 0.03 | 2026-04-06 | -98.52% | -176.631 |
| 1Y | 0.26 | 2025-10-06 | -99.81% | -74.407 |
| 2Y | 0.95 | 2024-10-04 | -99.95% | — |
| 5Y | 3.61 | 2023-03-09 | -99.99% | -15.640 |
CARISMA THERAPEUTICS INC (OTC:CARM) stock price today is $0.00, and today's volume is 1,601. CARM is up 0.000% today. The 30 day average volume is 7,107. CARM market cap is $20,894 with 41.79M shares outstanding.